NCT01461655

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Exploratory Study Evaluating the Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris, Using a Split-Face Model

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

The aim of this proof of principle study is to evaluate efficacy and safety of the sequential application of two marketed products for the treatment of acne vulgaris, using the Split-Face model

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	marketed topical retinoid	once daily application, 4 weeks
DRUG	marketed topical NSAID	once daily application, 4 weeks
DRUG	vehicle gel	once daily application, 4 weeks
DRUG	marketed topical retinoid	once daily application, 4 weeks

Timeline

• Start date: 2011-11-01
• Primary completion: 2012-04-01
• Completion: 2012-05-01
• First posted: 2011-10-28
• Last updated: 2025-03-10
• Results posted: 2013-12-04

Locations

1 site across 1 country: France